Phase I trial of nitric oxide for potential treatment of respiratory tract disorders/infections

Trial Profile

Phase I trial of nitric oxide for potential treatment of respiratory tract disorders/infections

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2013

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Asthma; Bacterial infections; Bronchiolitis; Cystic fibrosis-associated respiratory tract infections; Influenza virus infections; Pneumonia; Respiratory syncytial virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Aug 2013 This trial has been completed and the University of British Columbia has licensed this nitric oxide technology to AIT, according to an AIT media release.
    • 22 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top